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Abstract. 
We investigated the relationship between malaria infection and iron status in 531 pregnant women in South 
Kivu, Democratic Republic of the Congo. Sociodemographic data, information on morbidity, and clinical data 
were collected. A blood sample was collected at the first antenatal visit to diagnose malaria and measure serum 
ferritin (SF), soluble transferrin receptor, C-reactive protein, and 1-acid-glycoprotein. Malaria prevalence was 
7.5%. Median (interquartile range) SF (adjusted for inflammation) was significantly higher in malaria-infected 
(82.9 g/L [56.3–130.4]) than in non-infected (39.8 g/L [23.6–60.8]) women (P < 0.001). Similarly, estimated 
mean body iron stores was higher in malaria-infected women (P < 0.001). Malaria was significantly and 
independently associated with high levels of SF. Efforts to improve malaria prevention while correcting iron 
deficiency and anemia during pregnancy are warranted. 
In sub-Saharan Africa, pregnancy-associated malaria (PAM) and anemia are issues of 
public health concern.
1,2
 The etiology of anemia is multifactorial, but common causes include 
nutritional deficiencies (e.g., iron deficiency, ID), infections such as malaria and soil 
transmitted helminths, hemoglobinopathies, and other genetic disorders.
2
 According to World 
Health Organization (WHO), about 50% of all anemia cases may be due to ID. Hence, daily 
iron supplementation (IS) during pregnancy has been recommended to reduce the burden of 
anemia.
3
 This policy is being implemented in most sub-Saharan African countries, including 
the Democratic Republic of Congo (DRC). However, recent data from South Kivu, in the 
eastern part of DRC, show a lower-than-expected prevalence of ID
4,5
 and further raise 
questions on the possible negative outcome of IS on malaria. In South Kivu, prevalence of ID 
was 5.4% among nonpregnant women
5
 and 7.6% among pregnant women.
6
 Yet, in this same 
province, malaria remains common among pregnant women.
7
 
There might be an interaction between iron load and malaria, but it remains unclear 
whether high iron loads predispose to malaria and whether iron depletion is protective. 
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Studies in animal models have reported that placental iron overload in mice infected by 
Plasmodium berghei was associated with poor outcomes.
8
 In humans, among Beninese 
women, high iron levels increased the risk of PAM, including high Plasmodium falciparum 
density.
9
 Similarly, IS in Tanzanian preschool children was associated with increased 
morbidity and mortality due to infectious diseases, including malaria.
10
 In another study, ID 
among pregnant women was reported to protect against placental malaria.
11
 A meta-analysis 
concluded that IS does not increase the risk of falciparum malaria, although ID had a 
protective effect.
12
 
The present report is based on a study carried out to evaluate the relationship between 
iron load and PAM at the first antenatal visit before starting IS and intermittent preventive 
treatment (IPT) in South Kivu. 
This is a secondary analysis of data collected during a cross-sectional study conducted 
between December 2013 and March 2014 among pregnant women in the second trimester 
attending their first antenatal visit. The study was conducted in Miti-Murhesa, a rural health 
zone from South Kivu. Sampling methods are published elsewhere.
6
 
A thick blood smear stained with 3% Giemsa for 30 minutes was used to diagnose 
malaria and a thin blood smear for species identification, according to WHO guidelines. 
Serum ferritin (SF), soluble transferrin receptor (sTfR), C-reactive protein (CRP), and 1-
acid-glycoprotein (AGP) were determined by a sandwich enzyme-linked immunosorbent 
assay technique on a venous blood sample.
13
 
Ferritin is an acute phase protein known to increase during infection/inflammation. 
Therefore, SF was adjusted according to an individual’s inflammation status, defined using 
CRP > 5 mg/L and/or AGP > 1 g/L as cutoffs. Adjustment was done according to correction 
factors suggested by Thurnham et al.
14
: ferritin concentration multiplied by 0.77, 0.53, and 
0.75 during incubation (only CRP increased), early convalescence (both CRP and AGP 
increased), and late convalescence (only AGP increased), respectively. ID was defined as 
adjusted SF < 15 g/L. Body iron store (BIS, mg/kg) was calculated by using the Cook’s 
formula
15
: BIS =  [log10(sTfR * 1,000/ferritin)  2.8229]/0.1207. Based on BIS, ID was 
defined as BIS < 0 mg/kg. 
Anemia was defined as altitude-adjusted hemoglobin (Hb) < 110 g/L and severe anemia 
as Hb < 70 g/L. 
Statistical analyses were performed with STATA for Mac, version 12.1 (StataCorp, 
College Station, TX). The Mann–Whitney Wilcoxon and the T tests were used to compare 
medians or means, respectively, between two groups. Pearson’s 2, Fisher’s exact test, odd 
ratios, and 95% confidence intervals (CI) were used to test for associations between malaria 
and others variables. The logistic regression model was used to examine the independent 
association between malaria and different factors. For all analyses, the statistical significance 
level was fixed at < 0.05. 
The study was approved by the local Institutional Ethics Committee of the Catholic 
University of Bukavu and was authorized by the Ministry of Health office in the South Kivu 
Province. All participants gave an informed consent. Data from human immunodeficiency 
virus–positive women were excluded and patients managed according to the national 
guidelines. 
Five-hundred-thirty-one pregnant women, with a median (interquartile range, IQR) age of 
25.5 (21.1–31.3) years and between 12 and 24 weeks of gestational age, were recruited. 
Characteristics of the women and others results are reported elsewhere.
6
 More than a quarter 
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of the study population were primigravidae and half were in their fourth or higher pregnancy. 
Nearly 38% (199/530) and 16.5% (86/522) reported fever and antimalarial treatment, 
respectively, within the previous 3 months, whereas 63.8% (336/527) reported sleeping under 
insecticide-treated mosquito net (ITN) the prior night. The prevalence of anemia was 17.6%, 
including 0.2% severe anemia (N = 529). 
Overall malaria prevalence was 7.5% (95% CI: 5.4–10.1), with parasite density ranging 
between 160 and 48,000 parasites/L. The large majority of infections (38/40) were due to P. 
falciparum, with two due to Plasmodium malariae (320 and 360 parasites/L). SF, sTfR, 
AGP, CRP, and malaria status were available for 484 women. Median (IQR) ferritin (g/L) 
was 41.4 (24.6–64.6). Prevalence (95% CI) of inflammation was 23.9% (20.2–28.0). ID 
prevalence based on ferritin was 7.6% (5.4–10.4). Using BIS, ID was 2.9% (N = 485). No 
woman with ID was infected by P. falciparum parasite, whereas in those without ID (N = 
470) 7.4% were malaria infected. 
Adjusted median SF (IQR) was significantly higher in malaria-infected [82.9 g/L (56.3–
130.4)] than non-infected [39.8 g/L (23.6–60.8)] women; P < 0.001 (Figure 1). Similarly, 
mean (standard deviation) BIS (mg/kg) was significantly higher in malaria-infected [7.8 
(3.3); N = 35] than in non-infected women [5.7 (2.9); N = 449; P < 0.001]. Among the 35 
malaria-infected women with SF data, only one of them (infected with P. malariae) was iron 
deficient; P. falciparum was diagnosed in women with normal to high levels of SF. 
Malaria-infection was significantly and independently associated with not sleeping under 
ITN the prior night and with high ferritin level (Table 1). 
These results show that pregnant women with high SF had a significantly higher 
probability of being malaria-infected. However the direction of malaria-iron store interaction 
remains unclear. It is unclear whether high iron loads favor malaria infection or whether 
malaria causes high SF and BIS. In the first scenario, malaria parasites would benefit from 
iron-replete conditions to access iron for their metabolism and growth. In the second 
scenario, malaria would increase ferritin concentrations as it does for others acute phase 
proteins. Our data are consistent with either scenario. Inflammation was found in almost all 
infected women and ferritin levels were corrected for CRP/AGP levels. To our knowledge, 
there are no validated correction factors to adjust ferritin according to the presence of 
malaria, but data from population studies by others suggest that there is no difference in the 
prevalence of iron store depletion when correcting for CRP + AGP + malaria versus when 
correcting for CRP + AGP.
16
 This may indicate that correcting for inflammation using both 
CRP and AGP as was done in our study is sufficient for correcting malaria effect. However, 
the correction factors might be insufficient to correct for the effect of malaria beyond 
inflammation if malaria were to induce a depletion of iron stores. The definitive way to 
ascertain the causality relationship between iron stores and malaria is to carry out prospective 
studies in which the incidence of malaria is measured in groups of low and high ferritin 
and/or BIS, but based on available information by other studies, we suggest that the higher 
corrected ferritin levels among malaria infected women were likely not a consequence of, but 
reflected replete iron stores predisposing to malaria. 
If high iron loads favor malaria, then the next question is whether IS without effective 
malaria prevention during pregnancy might be harmful especially in iron-replete population. 
In South Kivu, ID does not seem to be common among women, regardless of pregnancy.
5,6
 A 
similar low ID prevalence was also found in preschool children in the same area.
4,5
 As 
mentioned previously, elsewhere IS has been associated with a higher risk of malaria during 
pregnancy
9
 and a higher risk of morbidity and mortality due to infectious diseases, including 
malaria, among preschool children.
10
 According to published data from others settings, ID 
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may protect against PAM.
9,11,12
 Therefore, IS in iron-replete women may increase the risk of 
malaria-infection and consequently malaria-related anemia. The underlying mechanisms are 
not clearly understood, but they may be related to the use of iron by malaria parasites for 
their growth and replication and to the impairment of host immunity.
17
 
Coverage of preventive interventions against malaria among pregnant women remains 
low in many countries. In 20 African countries, IPT coverage ( 3 doses of sulfadoxine–
pyrimethamine, SP) was 31% (95% uncertainty interval: 29–32%) in 2015.1 This is also the 
case in South Kivu, our study area, where according to the Ministry of Health, in 2016, only 
11% of pregnant women received three doses of SP, 55% two doses, and only 60% of 
pregnant women were using ITN. In addition to this low level of prevention, the spread of SP 
resistance is another concern in the prevention of PAM.
18
 
In South Kivu, 77.7% of pregnant women were supplemented in 2016 with daily iron 
(Ministry of Health). Unfortunately, we are unable to comment on the compliance. Ideally, IS 
should be given only to iron-deficient women. However, there are no field-deployable tests 
able to identify them. It has, therefore, been suggested that IS should be given along with 
effective preventive measures to reduce the risk of “iron-induced” malaria.19 WHO antenatal 
care guidelines include the option of decreasing the iron dose according to the burden of 
anemia and ID (from 30–60 mg/day to 120 mg/week).20 In places such as South Kivu, where 
ID is uncommon, a low iron dose might be safer. 
Limitations of our study include the cross-sectional design, the use of microscopy 
(instead of molecular techniques) to diagnose malaria, which could have underestimated its 
prevalence as submicroscopic-malaria is common during pregnancy, hence resulting in the 
relatively small number of parasitized-pregnant women, and the use of ferritin correction 
factors and a BIS formula determined from undiseased groups. Based on our findings, large-
scale longitudinal studies to measure the incidence of malaria in groups of low versus high 
iron stores and efforts to improve prevention against malaria, ID, and anemia during 
pregnancy are warranted in South Kivu. 
Received July 21, 2017. 
Accepted for publication October 1, 2017. 
Acknowledgments: 
We thank pregnant women who accepted to participate in this study. They also appreciate the commitment of 
the team that was involved in the study activities especially nurses and midwives of the Miti-Murhesa general 
referral hospital. We thank Balume Mulanga, Alfonsine Mashukano, Alves Namunesha, Ghislain Materanya, 
Jean-Marie Mpongo, and Nicolai Petry for their contribution in the collection, processing, storage, and shipment 
of blood samples. We are also thankful to Juergen Erhardt for blood analysis. 
Financial support: This study was supported by a grant from the Belgian “Commission Universitaire pour le 
Développement” (CUD). 
Authors’ addresses: Esto Bahizire, Center of Research in Epidemiology, Biostatistics and Clinical Research, Université 
Libre de Bruxelles, Brussels, Belgium, Centre de Recherche en Sciences Naturelles de Lwiro, Bukavu, DR Congo, and 
Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya, E-mail: esto.bahizire@gmail.com. Umberto 
D’Alessandro, Medical Research Council Unit The Gambia, Fajara, Banjul, The Gambia, and London School of Hygiene 
and Tropical Medicine, London, United Kingdom, E-mail: udalessandro@mrc.gm. Michèle Dramaix, Center of Research in 
Epidemiology, Biostatistics and Clinical Research, Université Libre de Bruxelles, Brussels, Belgium, E-mail: 
michele.dramaix@ulb.ac.be. Nicolas Dauby, Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-
Pierre, Brussels, Belgium, E-mail: nicolas_dauby@stpierre-bru.be. Fabrice Bahizire, Department of Medical Microbiology, 
University of Nairobi, Nairobi, Kenya, E-mail: fabricebahizire89@gmail.com. Kanigula Mubagwa, Department of 
Cardiovascular Sciences, KU Leuven, Leuven, Belgium, E-mail: kanigula.mubagwa@med.kuleuven.ac.be. Philippe 
Donnen, Center of Research in Health Policy and Systems-International Health, Université Libre de Bruxelles, Brussels, 
Belgium, E-mail: pdonnen@ulb.ac.be. 
Page 5 of 8 
REFERENCES 
<bok>1. WHO, 2016. Word Malaria Report 2016. Geneva, Switzerland: World Health 
Organization.</bok> 
<jrn>2. Balarajan Y, Ramakrishnan U, Özaltin E, Shankar AH, Subramanian SV, 2011. 
Anaemia in low-income and middle-income countries. Lancet 378: 2123–2135.</jrn> 
<bok>3. WHO, 2012. Guideline: Intermittent Iron and Folic Acid Supplementation in Non-
anaemic Pregnant Women. Geneva, Switzerland: World Health Organization.</bok> 
<jrn>4. Bahizire E, Bahwere P, Donnen P, Tugirimana PL, Balol’ebwami S, Dramaix M, 
Nfundiko C, Chirimwami R, Mubagwa K, 2017. High prevalence of anemia but low level 
of iron deficiency in preschool children during a low transmission period of malaria in 
rural Kivu, Democratic Republic of the Congo. Am J Trop Med Hyg 97: 489–496.</jrn> 
<jrn>5. Harvey-Leeson S et al., 2016. Anemia and micronutrient status of women of 
childbearing age and children 6–59 months in the Democratic Republic of the Congo. 
Nutrients 8: 98.</jrn> 
<jrn>6. Bahizire E, Tugirimana PL, Dramaix M, Zozo D, Bahati M, Mwale A, Meuris S, 
Donnen P, 2017. Malaria is more prevalent than iron deficiency among anemic pregnant 
women at the first antenatal visit in rural South Kivu. Am J Trop Med Hyg, doi: 
10.4269/ajtmh.17-0267.</jrn> 
<jrn>7. Bahizire E, Mitangala P, Donnen P, Balegamire S, Mulinganya G, Bahizi P, Senterre 
C, D’Alessandro U, Meuris S, Dramaix M, 2016. Malaria at the first antenatal visit: 
prevalence and associated factors in rural area in South Kivu, eastern part of the 
Democratic Republic of Congo. Med Afr Noire 63: 437–449.</jrn> 
<jrn>8. Penha-Goncalves C, Gozzelino R, de Moraes LV, 2014. Iron overload in 
Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death. Front 
Pharmacol 5: 155.</jrn> 
<jrn>9. Moya-Alvarez V, Cottrell G, Ouedraogo S, Accrombessi M, Massougbodgi A, Cot 
M, 2015. Does iron increase the risk of malaria in pregnancy? Open Forum Infect Dis 2: 
ofv038.</jrn> 
<jrn>10. Sazawal S et al., 2006. Effects of routine prophylactic supplementation with iron 
and folic acid on admission to hospital and mortality in preschool children in a high 
malaria transmission setting: community-based, randomised, placebo-controlled trial. 
Lancet 367: 133–143.</jrn> 
<jrn>11. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE, 2008. Decreased 
susceptibility to Plasmodium falciparum infection in pregnant women with iron 
deficiency. J Infect Dis 198: 163–166.</jrn> 
<jrn>12. Sangare L, van Eijk AM, Ter Kuile FO, Walson J, Stergachis A, 2014. The 
association between malaria and iron status or supplementation in pregnancy: a 
systematic review and meta-analysis. PLoS One 9: e87743.</jrn> 
<jrn>13. Erhardt JG, Estes JE, Pfeiffer CM, Biesalski HK, Craft NE, 2004. Combined 
measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-
reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked 
immunosorbent assay technique. J Nutr 134: 3127–3132.</jrn> 
<jrn>14. Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe 
GP, 2010. Adjusting plasma ferritin concentrations to remove the effects of subclinical 
Page 6 of 8 
inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr 92: 
546–555.</jrn> 
<jrn>15. Cook JD, Flowers CH, Skikne BS, 2003. The quantitative assessment of body iron. 
Blood 101: 3359–3364.</jrn> 
<jrn>16. Namaste SML et al., 2017. Adjusting ferritin concentrations for inflammation: 
biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) 
project. Am J Clin Nutr 106 (Suppl): 359S–371S.</jrn> 
<jrn>17. Prentice AM, 2008. Iron metabolism, malaria, and other infections: what is all the 
fuss about? J Nutr 138: 2537–2541.</jrn> 
<jrn>18. Enosse S, Magnussen P, Abacassamo F, Gomez-Olive X, Ronn AM, Thompson R, 
Alifrangis M, 2008. Rapid increase of Plasmodium falciparum dhfr/dhps resistant 
haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 
2002, in southern Mozambique. Malar J 7: 115.</jrn> 
<jrn>19. Neuberger A, Okebe J, Yahav D, Paul M, 2016. Oral iron supplements for children 
in malaria-endemic areas. Cochrane Database Syst Rev 2: CD006589.</jrn> 
<bok>20. WHO, 2016. WHO Recommendations on Antenatal Care for a Positive Pregnancy 
Experience. Geneva, Switzerland: Word Health Organization.</bok> 
FIGURE 1. Median of ferritin adjusted for inflammation among women without and with malaria. Mann–
Whitney Wilcoxon P < 0.001. 
TABLE 1 
Association between malaria, ITN, iron load, and inflammation in pregnant women 
     
Logistic model, N = 
480; 35 cases of 
malaria 
Variables n 
% 
Malaria 
OR (95% CI) P aOR (95% CI) P 
Age (years) – – – 0.798 – – 
  20 95 8.4 
1.52 (0.44–
5.25) 
– – – 
 > 20–35 364 7.7 
1.38 (0.47–
4.05) 
– – – 
 > 35 70 5.7 1 – – – 
Number of pregnancy – – – 0.431 – – 
 1 126 5.6 1 – – – 
 2–3 112 9.8 
1.85 (0.69–
4.95) 
– – – 
  4 246 6.9 
1.26 (0.51–
3.13) 
– – – 
Sleeping under ITN the prior 
night 
– – – 0.061 – 0.024 
 Yes 335 6.0 1 – 1 – 
 No 191 10.5 
1.85 (0.92–
3.72) 
– 
2.24 (1.12–
4.51) 
– 
Inflammation* – – – < 0.001 – – 
 Yes 116 20.7 
8.47 (3.80–
19.77) 
– – – 
 No 368 3.0 1 – – – 
Ferritin (ug/L, adjusted for 
inflammation)* 
– – – 0.005† – 0.021 
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 < 15 37 2.7 
3.56 (0.31–
41.39) 
– 
1.57 (0.14–
17.77) 
– 
 15 to  30 117 1.7 1 – 1 – 
 > 30 330 9.7 
6.23 (1.47–
26.38) 
– 
6.25 (1.47–
26.57) 
– 
aOR = adjusted odds ratio; CI = confidence interval; ITN = insecticide-treated mosquito net; OR = odds ratio. 
The following variables have been removed by the stepwise backward procedure: age, level of education, 
employment, marital status, number of pregnancy, fever within the last 3 months, anti-malarial treatment within 
the last 3 months, mid-upper arm circumference, retinol binding protein, and serum albumin. Note: ferritin was 
already adjusted for inflammation.
14 
* Inflammation: C-reactive protein > 5 mg/L and/or 1-acid-glycoprotein > 1 g/L. 
† Fisher exact. 
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